Logen

   
Google
 
Web NewDrugInformation.com

Logen


Drug - Logen
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Atropine Sulfate; Diphenoxylate Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.025MG;2.5MG
The potency of the active ingredient(s), Atropine Sulfate; Diphenoxylate Hydrochloride. May repeat for multiple part products.

Applicant - SUPERPHARM
The firm name holding legal responsibility for Logen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088962
The FDA assigned number to Logen. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Logen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 10, 1985
The date Logen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Logen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Logen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Superpharm Corp
The full name of the firm holding legal responsibility for the new application of Logen.

Logen